newsFirst patient dosed with novel RNA modifying enzyme inhibitor25 November 2022 | By Catherine Eckford (European Pharmaceutical Review)A Phase I trial for solid tumours has begun to assess STC-15, the first RNA methyltransferase modifying enzyme inhibitor.